Oldest pages

Jump to navigation Jump to search

Showing below up to 50 results in range #4,051 to #4,100.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Han B, et al. Cell Rep. (2015) cited as Ref 253 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  2. Wu J, et al. J. Hepatol. (2019) cited as Ref 254 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  3. Valenti G, et al. Cancer Res. (2017) cited as Ref 255 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  4. Gu D, et al. Mol. Cancer Ther. (2013) cited as Ref 256 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  5. Joost S, et al. Cancer Res. (2012) cited as Ref 257 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  6. Liu S, et al. Cancer Res. (2006) cited as Ref 258 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  7. Song Z, et al. PLoS ONE (2011) cited as Ref 259 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  8. Takahashi T, et al. Leuk. Res. (2011) cited as Ref 260 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  9. Takebe N, et al. Nat. Rev. Clin. Oncol. (2011) cited as Ref 261 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  10. Tanaka H, et al. Anticancer Res. (2009) cited as Ref 262 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  11. Kong Y, et al. Stem Cells (2015) cited as Ref 263 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  12. Zhu R, et al. Nat. Commun. (2019) cited as Ref 264 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  13. Guo E, et al. Oncol. Res. (2017) cited as Ref 265 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  14. Tiberi L, et al. Cancer Cell (2014) cited as Ref 266 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  15. Kim Bo Ram, et al. Cell Death & Differentiation (2019) cited as Ref 267 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  16. Wang F, et al. J. Cancer (2016) cited as Ref 268 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  17. Zinke J, et al. Mol. Cancer (2015) cited as Ref 269 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  18. Tang B, et al. Int. J. Cancer (2018) cited as Ref 270 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  19. Miele E, et al. BMC Cancer (2017) cited as Ref 271 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  20. Du W, et al. Neuro-Oncology (2015) cited as Ref 272 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  21. Chandimali Nisansala, et al. Cancer Gene Therapy (2018) cited as Ref 273 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  22. Zhang Q, et al. Cell (2017) cited as Ref 274 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  23. Hoesel B, et al. Mol. Cancer (2013) cited as Ref 275 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  24. Hayden MS, et al. Cell (2008) cited as Ref 276 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  25. May MJ, et al. Semin. Cancer Biol. (1997) cited as Ref 277 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  26. Novack DV, et al. Cell Res. (2011) cited as Ref 278 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  27. Perkins ND, et al. Cell Death Differ. (2006) cited as Ref 279 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  28. Sun SC, et al. Cell Res. (2011) cited as Ref 280 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  29. Xiao G, et al. Mol. Cell (2001) cited as Ref 281 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  30. Greten FR, et al. Cell (2004) cited as Ref 282 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  31. Taniguchi K, et al. Nat. Rev. Immunol. (2018) cited as Ref 283 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  32. Denz U, et al. Eur. J. Cancer (2006) cited as Ref 284 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  33. Karin M, et al. Cold Spring Harb. Perspect. Biol. (2009) cited as Ref 285 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  34. Prasad S, et al. Mol. Cell. Biochem. (2010) cited as Ref 286 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  35. Brown M, et al. Expert Opin. Ther. Targets (2008) cited as Ref 287 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  36. Hinz M, et al. J. Exp. Med. (2002) cited as Ref 288 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  37. Richmond A, et al. Nat. Rev. Immunol. (2002) cited as Ref 289 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  38. Gonzalez-Torres C, et al. Arch. Med. Res. (2017) cited as Ref 290 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  39. Vazquez-Santillan K, et al. Sci. Rep. (2016) cited as Ref 291 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  40. Kong L, et al. Int. J. Oncol. (2016) cited as Ref 292 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  41. Wang D, et al. Gastroenterology (2015) cited as Ref 293 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  42. Smith HA, et al. J. Mol. Med. (2013) cited as Ref 294 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:04, 20 May 2020)
  43. Zhang L, et al. PLoS ONE (2016) cited as Ref 295 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:05, 20 May 2020)
  44. Wang X, et al. J. Hematol. Oncol. (2016) cited as Ref 296 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:05, 20 May 2020)
  45. Li B, et al. Chem. Biol. Interact. (2017) cited as Ref 297 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:05, 20 May 2020)
  46. Karanikas V, et al. J. Transl. Med. (2008) cited as Ref 298 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:05, 20 May 2020)
  47. Liu S, et al. Oncotarget (2017) cited as Ref 299 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:05, 20 May 2020)
  48. Yang X, et al. Tumour Biol. (2016) cited as Ref 300 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:05, 20 May 2020)
  49. Han D, et al. Oncotarget (2015) cited as Ref 301 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:05, 20 May 2020)
  50. Burnett JP, et al. Cancer Lett. (2017) cited as Ref 302 in DOI: 10.1038/s41392-020-0110-5‏‎ (15:05, 20 May 2020)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)